Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Terminated 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Classical hematology 1

Conditions

Thrombocytopenia 2Lymphoma 2Leukemia 2Hematologic Diseases 2Transfusion Reaction 1Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 68Cyclophosphamide 44Methotrexate 41Daunorubicin 38Etoposide 34Vincristine 30Mercaptopurine 28Dexamethasone 24Radiotherapy 22Idarubicin 22Asparaginase 21Thioguanine 20Doxorubicin 19Prednisone 17Peripheral Blood Stem Cell Transplantation 17Imatinib Mesylate 16Busulfan 16pegaspargase 15Mitoxantrone 15Filgrastim 13Leucovorin 11fludarabine phosphate 10Hydrocortisone 10nilotinib 9Tretinoin 8Prednisolone 8Cyclosporine 8Hydroxyurea 7Epoetin Alfa 7Azacitidine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Leukemia × Platelet Transfusion × Clear all
NCT01642563 2015-07-28

IPTAS

Centro Nazionale Sangue

Phase 3 Terminated
456 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT00074763 2012-08-02

Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets

M.D. Anderson Cancer Center

Phase 3 Terminated
4 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Hematologic Diseases, Leukemia, Lymphoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡